Industry Research Reports
Home > Reports > Medical Devices & Consumables > Implantable Heart Failure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Implantable Heart Failure Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 119 Pages
Report ld: 5743636
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Implantable Heart Failure Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.
According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories: mechanical assistance, electrical-related technology and structural improvement. In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.
The North American market for Implantable Heart Failure Devices was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Implantable Heart Failure Devices was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Implantable Heart Failure Devices was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Implantable Heart Failure Devices market include Abbott, Medtronic, Jarvik Heart, Abiomed, Boston Scientific, Impulse Dynamics, SynCardia, Berlin Heart, Covia Medica, V-Wave, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Implantable Heart Failure Devices, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Implantable Heart Failure Devices market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Implantable Heart Failure Devices.
MARKET SEGMENTATION
By Company
- Abbott
- Medtronic
- Jarvik Heart
- Abiomed
- Boston Scientific
- Impulse Dynamics
- SynCardia
- Berlin Heart
- Covia Medica
- V-Wave
- Evaheart
- BrioHealth Solutions
- Hanyu Medical
- NewMed Medical
- Valgen Medtech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Mechanical Assistance Type
- Electrical Related Technology
- Structural Improvement Type
Segment by Application
- GradeⅠ- Ⅳ
- Grade Ⅱ- Ⅳ
- Grade Ⅲ -IV
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Implantable Heart Failure Devices manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Implantable Heart Failure Devices sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Implantable Heart Failure Devices sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Implantable Heart Failure Devices Product Introduction
1.2 Global Implantable Heart Failure Devices Market Size Forecast
1.2.1 Global Implantable Heart Failure Devices Sales Value (2021–2032)
1.2.2 Global Implantable Heart Failure Devices Sales Volume (2021–2032)
1.2.3 Global Implantable Heart Failure Devices Sales Price (2021–2032)
1.3 Implantable Heart Failure Devices Market Trends & Drivers
1.3.1 Implantable Heart Failure Devices Industry Trends
1.3.2 Implantable Heart Failure Devices Market Drivers & Opportunities
1.3.3 Implantable Heart Failure Devices Market Challenges
1.3.4 Implantable Heart Failure Devices Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Implantable Heart Failure Devices Players Revenue Ranking (2025)
2.2 Global Implantable Heart Failure Devices Revenue by Company (2021–2026)
2.3 Global Implantable Heart Failure Devices Sales Volume Ranking of Players (2025)
2.4 Global Implantable Heart Failure Devices Sales Volume by Company (2021–2026)
2.5 Global Implantable Heart Failure Devices Average Price by Company (2021–2026)
2.6 Key Manufacturers Implantable Heart Failure Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Implantable Heart Failure Devices Product Offerings
2.8 Key Manufacturers Start of Mass Production of Implantable Heart Failure Devices
2.9 Implantable Heart Failure Devices Market Competitive Analysis
2.9.1 Implantable Heart Failure Devices Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Implantable Heart Failure Devices Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Implantable Heart Failure Devices revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Implantable Heart Failure Devices Market Classification
3.1 Introduction by Type
3.1.1 Mechanical Assistance Type
3.1.2 Electrical Related Technology
3.1.3 Structural Improvement Type
3.1.4 Global Implantable Heart Failure Devices Sales Value by Type
3.1.4.1 Global Implantable Heart Failure Devices Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Implantable Heart Failure Devices Sales Value, by Type (2021–2032)
3.1.4.3 Global Implantable Heart Failure Devices Sales Value, by Type (%), 2021–2032
3.1.5 Global Implantable Heart Failure Devices Sales Volume by Type
3.1.5.1 Global Implantable Heart Failure Devices Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Implantable Heart Failure Devices Sales Volume, by Type (2021–2032)
3.1.5.3 Global Implantable Heart Failure Devices Sales Volume, by Type (%), 2021–2032
3.1.6 Global Implantable Heart Failure Devices Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 GradeⅠ- Ⅳ
4.1.2 Grade Ⅱ- Ⅳ
4.1.3 Grade Ⅲ -IV
4.2 Global Implantable Heart Failure Devices Sales Value by Application
4.2.1 Global Implantable Heart Failure Devices Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Implantable Heart Failure Devices Sales Value, by Application (2021–2032)
4.2.3 Global Implantable Heart Failure Devices Sales Value, by Application (%), 2021–2032
4.3 Global Implantable Heart Failure Devices Sales Volume by Application
4.3.1 Global Implantable Heart Failure Devices Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Implantable Heart Failure Devices Sales Volume, by Application (2021–2032)
4.3.3 Global Implantable Heart Failure Devices Sales Volume, by Application (%), 2021–2032
4.4 Global Implantable Heart Failure Devices Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Implantable Heart Failure Devices Sales Value by Region
5.1.1 Global Implantable Heart Failure Devices Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Implantable Heart Failure Devices Sales Value by Region (2021–2026)
5.1.3 Global Implantable Heart Failure Devices Sales Value by Region (2027–2032)
5.1.4 Global Implantable Heart Failure Devices Sales Value by Region (%), 2021–2032
5.2 Global Implantable Heart Failure Devices Sales Volume by Region
5.2.1 Global Implantable Heart Failure Devices Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Implantable Heart Failure Devices Sales Volume by Region (2021–2026)
5.2.3 Global Implantable Heart Failure Devices Sales Volume by Region (2027–2032)
5.2.4 Global Implantable Heart Failure Devices Sales Volume by Region (%), 2021–2032
5.3 Global Implantable Heart Failure Devices Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Implantable Heart Failure Devices Sales Value, 2021–2032
5.4.2 North America Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Implantable Heart Failure Devices Sales Value, 2021–2032
5.5.2 Europe Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Implantable Heart Failure Devices Sales Value, 2021–2032
5.6.2 Asia Pacific Implantable Heart Failure Devices Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Implantable Heart Failure Devices Sales Value, 2021–2032
5.7.2 South America Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Implantable Heart Failure Devices Sales Value, 2021–2032
5.8.2 Middle East & Africa Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Implantable Heart Failure Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Implantable Heart Failure Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Implantable Heart Failure Devices Sales Value, 2021–2032
6.2.2 Key Countries/Regions Implantable Heart Failure Devices Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Implantable Heart Failure Devices Sales Value, 2021–2032
6.3.2 United States Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Implantable Heart Failure Devices Sales Value, 2021–2032
6.4.2 Europe Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Implantable Heart Failure Devices Sales Value, 2021–2032
6.5.2 China Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.5.3 China Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Implantable Heart Failure Devices Sales Value, 2021–2032
6.6.2 Japan Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Implantable Heart Failure Devices Sales Value, 2021–2032
6.7.2 South Korea Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Implantable Heart Failure Devices Sales Value, 2021–2032
6.8.2 Southeast Asia Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Implantable Heart Failure Devices Sales Value, 2021–2032
6.9.2 India Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
6.9.3 India Implantable Heart Failure Devices Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Abbott Implantable Heart Failure Devices Product Offerings
7.1.5 Abbott Recent Developments
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Medtronic Implantable Heart Failure Devices Product Offerings
7.2.5 Medtronic Recent Developments
7.3 Jarvik Heart
7.3.1 Jarvik Heart Company Information
7.3.2 Jarvik Heart Introduction and Business Overview
7.3.3 Jarvik Heart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Jarvik Heart Implantable Heart Failure Devices Product Offerings
7.3.5 Jarvik Heart Recent Developments
7.4 Abiomed
7.4.1 Abiomed Company Information
7.4.2 Abiomed Introduction and Business Overview
7.4.3 Abiomed Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Abiomed Implantable Heart Failure Devices Product Offerings
7.4.5 Abiomed Recent Developments
7.5 Boston Scientific
7.5.1 Boston Scientific Company Information
7.5.2 Boston Scientific Introduction and Business Overview
7.5.3 Boston Scientific Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Boston Scientific Implantable Heart Failure Devices Product Offerings
7.5.5 Boston Scientific Recent Developments
7.6 Impulse Dynamics
7.6.1 Impulse Dynamics Company Information
7.6.2 Impulse Dynamics Introduction and Business Overview
7.6.3 Impulse Dynamics Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Impulse Dynamics Implantable Heart Failure Devices Product Offerings
7.6.5 Impulse Dynamics Recent Developments
7.7 SynCardia
7.7.1 SynCardia Company Information
7.7.2 SynCardia Introduction and Business Overview
7.7.3 SynCardia Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 SynCardia Implantable Heart Failure Devices Product Offerings
7.7.5 SynCardia Recent Developments
7.8 Berlin Heart
7.8.1 Berlin Heart Company Information
7.8.2 Berlin Heart Introduction and Business Overview
7.8.3 Berlin Heart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Berlin Heart Implantable Heart Failure Devices Product Offerings
7.8.5 Berlin Heart Recent Developments
7.9 Covia Medica
7.9.1 Covia Medica Company Information
7.9.2 Covia Medica Introduction and Business Overview
7.9.3 Covia Medica Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Covia Medica Implantable Heart Failure Devices Product Offerings
7.9.5 Covia Medica Recent Developments
7.10 V-Wave
7.10.1 V-Wave Company Information
7.10.2 V-Wave Introduction and Business Overview
7.10.3 V-Wave Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 V-Wave Implantable Heart Failure Devices Product Offerings
7.10.5 V-Wave Recent Developments
7.11 Evaheart
7.11.1 Evaheart Company Information
7.11.2 Evaheart Introduction and Business Overview
7.11.3 Evaheart Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Evaheart Implantable Heart Failure Devices Product Offerings
7.11.5 Evaheart Recent Developments
7.12 BrioHealth Solutions
7.12.1 BrioHealth Solutions Company Information
7.12.2 BrioHealth Solutions Introduction and Business Overview
7.12.3 BrioHealth Solutions Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 BrioHealth Solutions Implantable Heart Failure Devices Product Offerings
7.12.5 BrioHealth Solutions Recent Developments
7.13 Hanyu Medical
7.13.1 Hanyu Medical Company Information
7.13.2 Hanyu Medical Introduction and Business Overview
7.13.3 Hanyu Medical Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Hanyu Medical Implantable Heart Failure Devices Product Offerings
7.13.5 Hanyu Medical Recent Developments
7.14 NewMed Medical
7.14.1 NewMed Medical Company Information
7.14.2 NewMed Medical Introduction and Business Overview
7.14.3 NewMed Medical Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 NewMed Medical Implantable Heart Failure Devices Product Offerings
7.14.5 NewMed Medical Recent Developments
7.15 Valgen Medtech
7.15.1 Valgen Medtech Company Information
7.15.2 Valgen Medtech Introduction and Business Overview
7.15.3 Valgen Medtech Implantable Heart Failure Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Valgen Medtech Implantable Heart Failure Devices Product Offerings
7.15.5 Valgen Medtech Recent Developments
8 Industry Chain Analysis
8.1 Implantable Heart Failure Devices Industrial Chain
8.2 Implantable Heart Failure Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Implantable Heart Failure Devices Sales Model
8.5.2 Sales Channels
8.5.3 Implantable Heart Failure Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Implantable Heart Failure Devices Market Trends
Table 2. Implantable Heart Failure Devices Market Drivers & Opportunities
Table 3. Implantable Heart Failure Devices Market Challenges
Table 4. Implantable Heart Failure Devices Market Restraints
Table 5. Global Implantable Heart Failure Devices Revenue by Company (US$ Million), 2021–2026
Table 6. Global Implantable Heart Failure Devices Revenue Market Share by Company (2021–2026)
Table 7. Global Implantable Heart Failure Devices Sales Volume by Company (Units), 2021–2026
Table 8. Global Implantable Heart Failure Devices Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Implantable Heart Failure Devices Price by Company (K US$/Unit), 2021–2026
Table 10. Key Manufacturers Implantable Heart Failure Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Implantable Heart Failure Devices Product Type
Table 12. Key Manufacturers Start of Mass Production of Implantable Heart Failure Devices
Table 13. Global Implantable Heart Failure Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Implantable Heart Failure Devices revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Implantable Heart Failure Devices Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Implantable Heart Failure Devices Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Implantable Heart Failure Devices Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Implantable Heart Failure Devices Sales Market Share in Value by Type (2021–2026)
Table 20. Global Implantable Heart Failure Devices Sales Market Share in Value by Type (2027–2032)
Table 21. Global Implantable Heart Failure Devices Sales Volume by Type: 2021 vs 2025 vs 2032 (Units)
Table 22. Global Implantable Heart Failure Devices Sales Volume by Type (Units), 2021–2026
Table 23. Global Implantable Heart Failure Devices Sales Volume by Type (Units), 2027–2032
Table 24. Global Implantable Heart Failure Devices Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Implantable Heart Failure Devices Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Implantable Heart Failure Devices Price by Type (K US$/Unit), 2021–2026
Table 27. Global Implantable Heart Failure Devices Price by Type (K US$/Unit), 2027–2032
Table 28. Global Implantable Heart Failure Devices Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Implantable Heart Failure Devices Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Implantable Heart Failure Devices Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Implantable Heart Failure Devices Sales Market Share in Value by Application (2021–2026)
Table 32. Global Implantable Heart Failure Devices Sales Market Share in Value by Application (2027–2032)
Table 33. Global Implantable Heart Failure Devices Sales Volume by Application: 2021 vs 2025 vs 2032 (Units)
Table 34. Global Implantable Heart Failure Devices Sales Volume by Application (Units), 2021–2026
Table 35. Global Implantable Heart Failure Devices Sales Volume by Application (Units), 2027–2032
Table 36. Global Implantable Heart Failure Devices Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Implantable Heart Failure Devices Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Implantable Heart Failure Devices Price by Application (K US$/Unit), 2021–2026
Table 39. Global Implantable Heart Failure Devices Price by Application (K US$/Unit), 2027–2032
Table 40. Global Implantable Heart Failure Devices Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Implantable Heart Failure Devices Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Implantable Heart Failure Devices Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Implantable Heart Failure Devices Sales Value by Region (%), 2021–2026
Table 44. Global Implantable Heart Failure Devices Sales Value by Region (%), 2027–2032
Table 45. Global Implantable Heart Failure Devices Sales Volume by Region (Units): 2021 vs 2025 vs 2032
Table 46. Global Implantable Heart Failure Devices Sales Volume by Region (Units), 2021–2026
Table 47. Global Implantable Heart Failure Devices Sales Volume by Region (Units), 2027–2032
Table 48. Global Implantable Heart Failure Devices Sales Volume by Region (%), 2021–2026
Table 49. Global Implantable Heart Failure Devices Sales Volume by Region (%), 2027–2032
Table 50. Global Implantable Heart Failure Devices Average Price by Region (K US$/Unit), 2021–2026
Table 51. Global Implantable Heart Failure Devices Average Price by Region (K US$/Unit), 2027–2032
Table 52. Key Countries/Regions Implantable Heart Failure Devices Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Implantable Heart Failure Devices Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Implantable Heart Failure Devices Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Implantable Heart Failure Devices Sales Volume, (Units), 2021–2026
Table 56. Key Countries/Regions Implantable Heart Failure Devices Sales Volume, (Units), 2027–2032
Table 57. Abbott Company Information
Table 58. Abbott Introduction and Business Overview
Table 59. Abbott Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 60. Abbott Implantable Heart Failure Devices Product Offerings
Table 61. Abbott Recent Developments
Table 62. Medtronic Company Information
Table 63. Medtronic Introduction and Business Overview
Table 64. Medtronic Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 65. Medtronic Implantable Heart Failure Devices Product Offerings
Table 66. Medtronic Recent Developments
Table 67. Jarvik Heart Company Information
Table 68. Jarvik Heart Introduction and Business Overview
Table 69. Jarvik Heart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 70. Jarvik Heart Implantable Heart Failure Devices Product Offerings
Table 71. Jarvik Heart Recent Developments
Table 72. Abiomed Company Information
Table 73. Abiomed Introduction and Business Overview
Table 74. Abiomed Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 75. Abiomed Implantable Heart Failure Devices Product Offerings
Table 76. Abiomed Recent Developments
Table 77. Boston Scientific Company Information
Table 78. Boston Scientific Introduction and Business Overview
Table 79. Boston Scientific Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 80. Boston Scientific Implantable Heart Failure Devices Product Offerings
Table 81. Boston Scientific Recent Developments
Table 82. Impulse Dynamics Company Information
Table 83. Impulse Dynamics Introduction and Business Overview
Table 84. Impulse Dynamics Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 85. Impulse Dynamics Implantable Heart Failure Devices Product Offerings
Table 86. Impulse Dynamics Recent Developments
Table 87. SynCardia Company Information
Table 88. SynCardia Introduction and Business Overview
Table 89. SynCardia Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 90. SynCardia Implantable Heart Failure Devices Product Offerings
Table 91. SynCardia Recent Developments
Table 92. Berlin Heart Company Information
Table 93. Berlin Heart Introduction and Business Overview
Table 94. Berlin Heart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 95. Berlin Heart Implantable Heart Failure Devices Product Offerings
Table 96. Berlin Heart Recent Developments
Table 97. Covia Medica Company Information
Table 98. Covia Medica Introduction and Business Overview
Table 99. Covia Medica Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 100. Covia Medica Implantable Heart Failure Devices Product Offerings
Table 101. Covia Medica Recent Developments
Table 102. V-Wave Company Information
Table 103. V-Wave Introduction and Business Overview
Table 104. V-Wave Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 105. V-Wave Implantable Heart Failure Devices Product Offerings
Table 106. V-Wave Recent Developments
Table 107. Evaheart Company Information
Table 108. Evaheart Introduction and Business Overview
Table 109. Evaheart Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 110. Evaheart Implantable Heart Failure Devices Product Offerings
Table 111. Evaheart Recent Developments
Table 112. BrioHealth Solutions Company Information
Table 113. BrioHealth Solutions Introduction and Business Overview
Table 114. BrioHealth Solutions Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 115. BrioHealth Solutions Implantable Heart Failure Devices Product Offerings
Table 116. BrioHealth Solutions Recent Developments
Table 117. Hanyu Medical Company Information
Table 118. Hanyu Medical Introduction and Business Overview
Table 119. Hanyu Medical Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 120. Hanyu Medical Implantable Heart Failure Devices Product Offerings
Table 121. Hanyu Medical Recent Developments
Table 122. NewMed Medical Company Information
Table 123. NewMed Medical Introduction and Business Overview
Table 124. NewMed Medical Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 125. NewMed Medical Implantable Heart Failure Devices Product Offerings
Table 126. NewMed Medical Recent Developments
Table 127. Valgen Medtech Company Information
Table 128. Valgen Medtech Introduction and Business Overview
Table 129. Valgen Medtech Implantable Heart Failure Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 130. Valgen Medtech Implantable Heart Failure Devices Product Offerings
Table 131. Valgen Medtech Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Key Suppliers of Raw Materials Lists
Table 134. Implantable Heart Failure Devices Downstream Customers
Table 135. Implantable Heart Failure Devices Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Implantable Heart Failure Devices Product Picture
Figure 2. Global Implantable Heart Failure Devices Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 4. Global Implantable Heart Failure Devices Sales Volume (Units), 2021–2032
Figure 5. Global Implantable Heart Failure Devices Sales Price (K US$/Unit), 2021–2032
Figure 6. Implantable Heart Failure Devices Report Years Considered
Figure 7. Global Implantable Heart Failure Devices Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Implantable Heart Failure Devices Sales Volume Ranking of Players (Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Implantable Heart Failure Devices Revenue in 2025
Figure 10. Implantable Heart Failure Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Mechanical Assistance Type Picture
Figure 12. Electrical Related Technology Picture
Figure 13. Structural Improvement Type Picture
Figure 14. Global Implantable Heart Failure Devices Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Implantable Heart Failure Devices Sales Value Market Share by Type, 2025 & 2032
Figure 16. Global Implantable Heart Failure Devices Sales Volume by Type (Units), 2021 vs 2025 vs 2032
Figure 17. Global Implantable Heart Failure Devices Sales Volume Market Share by Type, 2025 & 2032
Figure 18. Global Implantable Heart Failure Devices Price by Type (K US$/Unit), 2021–2032
Figure 19. Product Picture of GradeⅠ- Ⅳ
Figure 20. Product Picture of Grade Ⅱ- Ⅳ
Figure 21. Product Picture of Grade Ⅲ -IV
Figure 22. Global Implantable Heart Failure Devices Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Implantable Heart Failure Devices Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Implantable Heart Failure Devices Sales Volume by Application (Units), 2021 vs 2025 vs 2032
Figure 25. Global Implantable Heart Failure Devices Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Implantable Heart Failure Devices Price by Application (K US$/Unit), 2021–2032
Figure 27. North America Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 28. North America Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 30. Europe Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Implantable Heart Failure Devices Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 34. South America Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Implantable Heart Failure Devices Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Implantable Heart Failure Devices Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Implantable Heart Failure Devices Sales Volume (%), 2021–2032
Figure 39. United States Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 40. United States Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 43. Europe Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 45. China Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 46. China Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 47. China Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 49. Japan Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 57. India Implantable Heart Failure Devices Sales Value (US$ Million), 2021–2032
Figure 58. India Implantable Heart Failure Devices Sales Value by Type (%), 2025 vs 2032
Figure 59. India Implantable Heart Failure Devices Sales Value by Application (%), 2025 vs 2032
Figure 60. Implantable Heart Failure Devices Industrial Chain
Figure 61. Implantable Heart Failure Devices Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Implantable Heart Failure Devices market?
The top companies in the global Implantable Heart Failure Devices market are Abbott、Medtronic、Jarvik Heart.
Related Reports
Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 159
USD 4900.00
(Single User License)
Global Implantable Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 92
USD 4250.00
(Single User License)
Global Implantable Heart Failure Devices Market Research Report 2026
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 120
USD 2900.00
(Single User License)
Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 153
USD 4900.00
(Single User License)
Global Implantable Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
Implantable Heart Failure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 3950.00
(Single User License)
Global Implantable Heart Failure Devices Market Research Report 2025
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
Global and United States Implantable Heart Failure Devices Market Report & Forecast 2024-2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 135
USD 4350.00
(Single User License)
Global Implantable Heart Failure Devices Market Research Report 2024
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 92
USD 2900.00
(Single User License)
Global Implantable Heart Failure Devices Market Insights, Forecast to 2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published Date: 2024-06-11
Pages: 151
USD 4900.00
(Single User License)
Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 159
USD 4900.00 (Single User License)Global Implantable Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Implantable Heart Failure Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 92
USD 4250.00 (Single User License)Global Implantable Heart Failure Devices Market Research Report 2026
The global Implantable Heart Failure Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 120
USD 2900.00 (Single User License)Global Implantable Heart Failure Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Implantable Heart Failure Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 153
USD 4900.00 (Single User License)Global Implantable Heart Failure Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Implantable Heart Failure Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
USD 4250.00 (Single User License)Implantable Heart Failure Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Implantable Heart Failure Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
USD 3950.00 (Single User License)Global Implantable Heart Failure Devices Market Research Report 2025
The global market for Implantable Heart Failure Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 96
USD 2900.00 (Single User License)Global and United States Implantable Heart Failure Devices Market Report & Forecast 2024-2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 135
USD 4350.00 (Single User License)Global Implantable Heart Failure Devices Market Research Report 2024
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 92
USD 2900.00 (Single User License)Global Implantable Heart Failure Devices Market Insights, Forecast to 2030
Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.
Published: 2024-06-11
Pages: 151
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now